CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for DiamiR Biosciences Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

DiamiR Biosciences Corp
11 Deer Park Drive, Suite 102G
Phone: (732) 823-1143p:732 823-1143 MONMOUTH JUNCTION, NJ  08852  United States Fax: (732) 823-1497f:732 823-1497

Business Summary
DiamiR Biosciences Corp., through its wholly owned subsidiary, DiamiR, LLC, is a molecular diagnostic company focused on development and commercialization of blood-based tests for minimally invasive risk assessment and monitoring of mild cognitive impairment (MCI), Alzheimer’s disease (AD), Parkinson’s disease (PD), and other neurodegenerative diseases (NDs). The Company's proprietary technology is developed based on quantitative analysis of organ-enriched, i.e. present at higher concentration in specific organs or tissues, microRNAs (miRNAs) in plasma. Its primary testing platform targets brain-enriched and inflammation-associated miRNAs. The Company is engaged in the development of CogniMIR, which is a proprietary test for early detection and risk stratification of Alzheimer’s disease and mild cognitive impairment. It collaborates with academic centers, disease foundations, and biopharma companies. The Company has the capacity to process between about 3500 - 5500 tests per year.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
8/31/20255/31/2024YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Executive Chairman of the Board, Secretary, Treasurer Kira S.Sheinerman 54
Chief Executive Officer, Director Nominee AlidadMireskandari 56
Chief Financial Officer Gary R.Anthony 63
4 additional Officers and Directors records available in full report.

General Information
Number of Employees: 5 (As of 5/31/2024)
Outstanding Shares: 4,440,891 (As of 8/31/2025)
Shareholders: 5
Federal Tax Id: 271523595
Fax Number: (732) 823-1497


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, October 29, 2025